Evidence map›Paper›PMID 35781670›Full record

ArticleJournal of cell communication and signaling2022

Connexin 32 overexpression increases proliferation, reduces gap junctional intercellular communication, motility and epithelial-to-mesenchymal transition in Hs578T breast cancer cells.

Deniz Ugur, Taha Bugra Gungul, Simge Yucel, Engin Ozcivici, Ozden Yalcin-Ozuysal, Gulistan Mese

Open access · greenAbstract read
In one paragraph

Article in Journal of cell communication and signaling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Beyond the gap: moonlighting functions of connexins in cancer.Cell communication and signaling : CCS · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Deniz UgurDepartment of Molecular Biology and Genetics, Izmir Institute of Technology, Urla, Izmir, 35430, Turkey.
Taha Bugra GungulDepartment of Molecular Biology and Genetics, Izmir Institute of Technology, Urla, Izmir, 35430, Turkey.
Simge YucelDepartment of Molecular Biology and Genetics, Izmir Institute of Technology, Urla, Izmir, 35430, Turkey.
Engin OzciviciDepartment of Bioengineering, Izmir Institute of Technology, Urla, Izmir, Turkey.
Ozden Yalcin-OzuysalDepartment of Molecular Biology and Genetics, Izmir Institute of Technology, Urla, Izmir, 35430, Turkey.
Gulistan MeseDepartment of Molecular Biology and Genetics, Izmir Institute of Technology, Urla, Izmir, 35430, Turkey. gulistanmese@iyte.edu.tr.ORCID http://orcid.org/0000-0003-0458-8684
Izmir Institute of Technology · TR

Funding

Izmir Yüksek Teknoloji Enstitüsü 2019IYTE0235Türkiye Bilimler Akademisi GEBIP2017Türkiye Bilimsel ve Teknolojik Araştirma Kurumu 114Z874
6 · The paper itself

Abstract

Connexins (Cx) are primary components of gap junctions that selectively allow molecules to be exchanged between adjacent cells, regulating multiple cellular functions. Along with their channel forming functions, connexins play a variety of roles in different stages of tumorigenesis and their roles in tumor initiation and progression is isoform- and tissue-specific. While Cx26 and Cx43 were downregulated during breast tumorigenesis, Cx32 was accumulated in the cytoplasm of the cells in lymph node metastasis of breast cancers and Cx32 was further upregulated in metastasis. Cx32's effect on cell proliferation, gap junctional communication, hemichannel activity, cellular motility and epithelial-to-mesenchymal transition (EMT) were investigated by overexpressing Cx32 in Hs578T and MCF7 breast cancer cells. Additionally, the expression and localization of Cx26 and Cx43 upon Cx32 overexpression were examined by Western blot and immunostaining experiments, respectively. We observed that MCF7 cells had endogenous Cx32 while Hs578T cells did not and when Cx32 was overexpressed in these cells, it caused a significant increase in the percentages of Hs578T cells at the S phase in addition to increasing their proliferation. Further, while Cx32 overexpression did not induce hemichannel activity in either cell, it decreased gap junctional communication between Hs578T cells. Additionally, Cx32 was mainly observed in the cytoplasm in both cells, where it did not form gap junction plaques but Cx32 overexpression reduced Cx43 levels without affecting Cx26. Moreover, migration and invasion potentials of Hs578T and migration in MCF7 were reduced upon Cx32 overexpression. Finally, the protein level of mesenchymal marker N-cadherin decreased while epithelial marker ZO-1 and E-cadherin increased in Hs578T cells. We observed that Cx32 overexpression altered cell proliferation, communication, migration and EMT in Hs578T, suggesting a tumor suppressor role in these cells while it had minor effects on MCF7 cells.

Indexed as

Breast cancerConnexin 32EMTGJICMotilityProliferation

Identifiers

PMID35781670
PMCPMC9411387
OpenAlexW4283794471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.